New York State Teachers Retirement System raised its position in Addus HomeCare Co. (NASDAQ:ADUS – Free Report) by 1.2% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 8,510 shares of the company’s stock after acquiring an additional 100 shares during the period. New York State Teachers Retirement System’s holdings in Addus HomeCare were worth $1,132,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors and hedge funds have also bought and sold shares of the company. UMB Bank n.a. lifted its holdings in shares of Addus HomeCare by 64.2% during the 2nd quarter. UMB Bank n.a. now owns 225 shares of the company’s stock valued at $26,000 after purchasing an additional 88 shares during the last quarter. Quest Partners LLC acquired a new position in Addus HomeCare during the 2nd quarter valued at about $31,000. EntryPoint Capital LLC purchased a new stake in Addus HomeCare in the first quarter valued at about $44,000. Innealta Capital LLC acquired a new stake in Addus HomeCare in the second quarter worth about $44,000. Finally, Sandia Investment Management LP acquired a new stake in Addus HomeCare in the second quarter worth about $58,000. 95.35% of the stock is owned by hedge funds and other institutional investors.
Addus HomeCare Price Performance
NASDAQ ADUS opened at $127.58 on Friday. The company has a fifty day moving average of $129.60 and a 200 day moving average of $121.40. The company has a market capitalization of $2.31 billion, a PE ratio of 29.19, a P/E/G ratio of 2.30 and a beta of 1.04. Addus HomeCare Co. has a 1 year low of $81.51 and a 1 year high of $136.12.
Analyst Upgrades and Downgrades
Several equities analysts have recently issued reports on ADUS shares. TD Cowen upped their price objective on shares of Addus HomeCare from $128.00 to $137.00 and gave the company a “buy” rating in a report on Thursday, August 8th. Royal Bank of Canada cut their price target on shares of Addus HomeCare from $141.00 to $136.00 and set an “outperform” rating on the stock in a research note on Wednesday. Oppenheimer lifted their price objective on shares of Addus HomeCare from $140.00 to $145.00 and gave the stock an “outperform” rating in a research note on Monday, September 23rd. KeyCorp started coverage on shares of Addus HomeCare in a report on Friday, October 11th. They set an “overweight” rating and a $150.00 price objective on the stock. Finally, Stephens raised their target price on Addus HomeCare from $143.00 to $145.00 and gave the stock an “overweight” rating in a research note on Wednesday. One analyst has rated the stock with a sell rating, eight have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $131.63.
Get Our Latest Report on Addus HomeCare
Insider Buying and Selling at Addus HomeCare
In related news, EVP Michael D. Wattenbarger sold 21,917 shares of the firm’s stock in a transaction on Monday, August 26th. The shares were sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the sale, the executive vice president now owns 7,215 shares in the company, valued at approximately $961,687.35. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other Addus HomeCare news, EVP Michael D. Wattenbarger sold 21,917 shares of the stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the transaction, the executive vice president now owns 7,215 shares in the company, valued at approximately $961,687.35. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Esteban Lopez sold 500 shares of the firm’s stock in a transaction that occurred on Tuesday, September 10th. The shares were sold at an average price of $127.50, for a total value of $63,750.00. Following the completion of the sale, the director now directly owns 3,366 shares in the company, valued at approximately $429,165. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 22,917 shares of company stock valued at $3,050,082. 4.60% of the stock is owned by company insiders.
Addus HomeCare Company Profile
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Featured Articles
- Five stocks we like better than Addus HomeCare
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Airbnb Stock Attracts Attention With Strong Cash Flow Strategy
- What is the Shanghai Stock Exchange Composite Index?
- MarketBeat Week in Review – 11/4 – 11/8
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Trump’s Return: Which Sectors Will Benefit Most?
Want to see what other hedge funds are holding ADUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Addus HomeCare Co. (NASDAQ:ADUS – Free Report).
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.